Sound stimulates blind retina to transmit signals to the brain in new study


Ultrasonic retinal prosthesis has been achieved by a research group at UCLA. It is a step towards a non-invasive retinal prosthesis that works without invasive eye surgery.

Sound stimulates blind retina to transmit signals to the brain in new study

Retinal degenerative diseases that are caused by progressive degeneration of the light-sensitive photoreceptors in the retina reman among the major causes of vision loss and blindness, affecting tens of millions of people worldwide.

Although the rods and cones which are the light-sensitive cells of the retina have completely degenerated, the neural circuitries connected to the brain are mostly well preserved providing the opportunity to restore vision by directly stimulating the retinal neurons.

A new solution based on activating these neurons by ultrasound has been achieved by a research group led by Dr Qifa Zhou, a professor of Biomedical Engineering and Ophthalmology, and Dr Mark S. Humayun, a professor of Ophthalmology and Biomedical Engineering and one of the inventors of Argus II, at the University of Southern California in Los Angeles (UCLA).

“This is a step towards a non-invasive retinal prosthesis that works without invasive eye surgeries,” Dr Zhou said in a university news release. “Special glasses with a camera and an ultrasound transducer are intended to give blind and partially sighted people a new view of the world.”

The study, published in BME Frontiers,1 was funded by National Eye Institute.
According to the university, to see if this approach could work, investigators stimulated the rat’s eyes with ultrasound waves, sound with a frequency far above what a human can hear. These high-frequency sounds can be well-manipulated and can be focused on a desired area of the eye. This approach made it possible to activate small groups of neurons in the blind rat’s eye, just like light signals can activate a normal eye.

The mechanical pressure by sound can activate neurons in the eye and send signals to the brain. For a comparable experience, anyone can feel light phosphenes by rubbing your eyes or by gently pushing your eyeballs while the eyes are closed.

“The challenge remains to enable ultrasound elicited visual perception so that it can provide useful vision for the blind,” said Dr Humayun, who is a pioneer in the field of retinal prosthesis.

“We know that ultrasound can generate well-controlled mechanical pressure, the acoustic radiation force, and it could be utilized to active neurons,” said Gengxi Lu, one of Dr Zhou's PhD students who recently presented the results of the research at a conference of the Acoustical Society of America in Seattle.
“It still needs to be figured out how exactly the mechanical pressure activated retinal neurons”

According to the university, the study is now at an earlier stage of developing a device to conduct human experiments. A major limitation of animal experiments is that unlike in humans we cannot get answers about their visual experiences during ultrasound stimulation of the eye. The team resolved this problem by measuring visual activities directly from the rat’s visual brain area known as the superior colliculus to which the optic nerve is directly connected.

By placing a multi-electrode array in this area, it was possible to record retinal activation by electrophysiology. The study demonstrated that when the ultrasound is projected as a pattern on the retina (for example the letter 'C') it was possible to measure corresponding activities in the superior colliculus.

One of the most important requirements of the visual prosthesis is that the user can see images as sharply as possible. To accomplish this, the incoming images should contain many individual points. The camera attached to the system may be able to handle this, but whether the sound waves are capable to transmit such small details to the retinal neurons without merging into each other?

“The resolution issue of the experimental system is not yet over,” said Xuejun Qian, a postdoctoral researcher at Dr Zhou’s lab who first demonstrated ultrasound retinal stimulation in blind rats in vivo.

“In rats, the ultrasound beam stimulated a circular area of the retina with a diameter of about 250 millionth of a meter while individual neurons that are only a few millionths of a millimetre in size are packed together in the retina,” Qian explained. “Hence, for achieving better resolution, we need to experiment with higher-frequency ultrasound beams.”

The experiments conducted by the team showed that the neurons gave off the strongest signal when they were activated about five times per second. But human brains have a much higher calculation speed, so they may see each image separately at this speed. Because of this limitation, the image of a person sitting across you may appear very jerky. Film and video game makers are aware that images can be smooth only at a frame rate of 24 frames per second. When we tested at such a high frame rate, the neurons in the rat eyes failed.

Dr Biju Thomas an associate professor of Research Ophthalmology, said in the university release that he believes investigators can at least partially solve this issue. Their experiments show that the higher the frequency of the ultrasound, the more strongly the neurons are activated. This can compensate for the attenuation that a higher frame rate brings.
Ten frames per second should be sufficient for successful sending of the signals to the brain,” Gengxi Lu said in the university news release.

There is a pending patent on this new ultrasound stimulation system. A Texas-based company called Nanoscope Technologies LLC, which is mainly focused on gene therapy for blindness, will license the technique and provide support for conducting future rabbit and monkey experiments. This makes Dr Zhou optimistic about the moment when a blind person, who is willing and able to afford it, can have a vision prosthesis fitted. If the upcoming experiments are successful, this novel technology could be translated into human clinical trials within the next 3 to 5 years.

1. Xuejun Qian, Gengxi Lu, Biju B. Thomas, Runzi , Ziaoang Chen, K. Kirk Shung, Mark Humayun, Qifa Zhou, et al; Noninvasive Ultrasound Retinal Stimulation for Vision Restoration at High Spatiotemporal Resolution; BME Frontiers; doi 10.34133/2022/9829316
Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.